Product R&D
Since the beginning of self transformation, Kuancheng Technology has been committed to developing good products that can effectively help people solve practical problems, so that Chinese patients can truly enjoy the health benefits of scientific and technological progress.
At present, the company has established a product R&D team with many highly educated, high-quality and high-tech employees, and has all the R&D capabilities necessary for product development from product initiation, product R&D, product production, quality control to clinical research. Through independent R&D or cooperation with domestic and international top medical device companies and research institutions, Research and develop innovative medical devices for diseases with high incidence in China and no effective non drug treatment means. At present, two product chains including 17 new products have been established, covering many disease fields such as digestive system and respiratory system.
In the future development, Kuancheng Technology will continue to strengthen R&D investment, continue to develop different disease fields, and successively launch a series of products, so that professional health services and advanced product technologies can benefit thousands of families.
Clinical research
In order to make the clinical application and scientific research of the salt aerosol therapy more solid, Kuancheng Technology, together with several hospitals in the province, carried out the clinical trial of the salt aerosol therapy instrument in the field of children/adults' breathing, as well as the scientific research of bacteriostasis, anti infection and other projects.
（1）Clinical trials
Clinical institutions | Clinical trials |
Nanjing Children's Hospital (lead) The Second Affiliated Hospital of Nanjing Medical University and the First Affiliated Hospital of Nanjing Medical University (participants) | A multicenter, randomized, single blind, blank, parallel controlled clinical trial of the effectiveness and safety of the saline sol therapeutic instrument in the auxiliary treatment of children with bronchial asthma and allergic rhinitis |
The First Affiliated Hospital of Nanjing Medical University (lead) Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing Chest Hospital, Affiliated Middle University Hospital of Southeast University and Jiangsu Second Hospital of Traditional Chinese Medicine (participated) | A multicenter, randomized, single blind, blank parallel controlled clinical trial of the effectiveness and safety of saline sol therapeutic apparatus as an auxiliary treatment for stable chronic obstructive pulmonary disease |
（2）Clinical research
Partner | Name of clinical project |
Nanjing University of Traditional Chinese Medicine | Study on the therapeutic effect and mechanism of salt therapy combined with aerosol inhalation on rats with chronic obstructive pulmonary disease |
Cooperative unit of Jiangsu Key Laboratory of Medical Molecular Technology, Nanjing University | Mechanism of effective intervention of dry salt aerosol on chronic obstructive pulmonary disease |
（3）Research project
Participating hospitals | Entry name |
Wuxi Huishan District Rehabilitation Hospital Jiangsu Zhongshan Elderly Rehabilitation Hospital Nanjing Qixia District Hospital | Project name: inhibition of multi drug resistant bacteria |
Jiangsu Provincial People's Hospital Jiangsu Zhongshan Elderly Rehabilitation Hospital Nanjing Qixia District Hospital | Control of airway inflammation and pulmonary infection |
A multicenter clinical trial on the safety and effectiveness of the treatment of 'postprandial discomfort syndrome' and 'functional constipation' was carried out for the digestive tract biofeedback gastrointestinal motility instrument product, which was completely unblinded in 2017. The total effective rate of the two prescriptions was 81.94%. It is the only equipment of the same kind on the market that has undergone multicenter clinical trials.
Clinical items | Postprandial discomfort syndrome | Functional constipation |
Entry name | Results Clinical trial on efficacy and safety of biofeedback gastrointestinal motility instrument in the treatment of postprandial discomfort syndrome | Clinical trial on efficacy and safety of biofeedback gastrointestinal motility instrument in the treatment of functional constipation |
Clinical institutions |
The Second Affiliated Hospital of Nanjing Medical University Jiangsu Provincial Hospital of Integrated Traditional and Western Medicine |
The Second Affiliated Hospital of Nanjing Medical University Jiangsu Provincial Hospital of Integrated Traditional and Western Medicine |
Test purpose | To evaluate the efficacy and safety of the biofeedback gastrointestinal motility instrument developed by Nanjing Kuancheng Science and Technology Co., Ltd. in the treatment of postprandial discomfort syndrome, with the blank as the control. | To evaluate the efficacy and safety of the biofeedback gastrointestinal motility instrument developed by Nanjing Kuancheng Science and Technology Co., Ltd. in the treatment of functional constipation, with the blank as the control. |
Timing | 2016.12.12-2017.11.18 | 2016.12.16-2017.8.25 |
Test result | The biofeedback gastrointestinal motility instrument developed by Nanjing Kuancheng Technology Co., Ltd. is safe and effective in the treatment of postprandial discomfort syndrome, with a total effective rate of 81.94% | The biofeedback gastrointestinal motility instrument developed by Nanjing Kuancheng Technology Co., Ltd. is safe and effective in the treatment of functional constipation, with a total effective rate of 81.94% |